Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
126.85
+1.06 (+0.84%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,312,463
Open
126.15
Bid (Size)
126.90 (6)
Ask (Size)
127.32 (1)
Prev. Close
125.79
Today's Range
125.99 - 127.90
52wk Range
75.56 - 138.28
Shares Outstanding
N/A
Dividend Yield
1.39%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
April 26, 2024
Via
Benzinga
Is NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) a Strong Candidate for Quality Investing?
April 25, 2024
Why NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) qualifies as a quality stock.
Via
Chartmill
Performance
YTD
+24.23%
+24.23%
1 Month
-0.94%
-0.94%
3 Month
+17.38%
+17.38%
6 Month
+35.67%
+35.67%
1 Year
+52.81%
+52.81%
More News
Read More
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
April 24, 2024
Via
Benzinga
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
Via
InvestorPlace
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
April 24, 2024
Via
The Motley Fool
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
Via
InvestorPlace
Why Novo Nordisk Topped the Market Today
April 22, 2024
Via
The Motley Fool
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Via
The Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
Via
The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
April 23, 2024
Via
InvestorPlace
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
April 22, 2024
Via
Benzinga
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
Via
MarketBeat
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
April 20, 2024
Via
The Motley Fool
MarketBeat Week in Review – 4/15 - 4/19
April 20, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
Via
The Motley Fool
3 Biotech Stocks Set to Double by 2028
April 20, 2024
Via
InvestorPlace
Got $500? 3 Healthcare Stocks to Buy and Hold Forever
April 19, 2024
Via
The Motley Fool
German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
April 18, 2024
Via
Benzinga
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
April 18, 2024
Via
Benzinga
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
April 18, 2024
Via
Investor's Business Daily
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
April 17, 2024
Via
The Motley Fool
Powell And The Great Indecision
April 16, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Interest Rates
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
April 16, 2024
Via
InvestorPlace
Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges
April 16, 2024
Via
InvestorPlace
Topics
ETFs
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.